Wendy Cameron
Director/Miembro de la Junta en Beijing Tong Ren Tang Ming Qi Group LLC .
Cargos activos de Wendy Cameron
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Beijing Tong Ren Tang Ming Qi Group LLC | Director/Miembro de la Junta | 01/01/2003 | - |
Corporate Officer/Principal | 23/10/2009 | - |
Historial de carrera de Wendy Cameron
Antiguos cargos conocidos de Wendy Cameron.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Director/Miembro de la Junta | 01/01/2002 | 29/06/2018 |
Independent Dir/Board Member | 01/01/2002 | 29/06/2018 | |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Director/Miembro de la Junta | 01/01/2002 | 02/10/2007 |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | Consejero General | 01/01/1981 | 01/01/1998 |
Ventas & Marketing | 01/01/1981 | 01/01/1998 | |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Presidente | 14/07/2011 | - |
Washington Health System Foundation | Director/Miembro de la Junta | 13/05/2010 | - |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Director/Miembro de la Junta | 01/01/2002 | - |
Independent Dir/Board Member | 13/07/2011 | - |
Formación de Wendy Cameron.
Otterbein College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 8 |
Reino Unido | 2 |
Operativa
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 4 |
Consumer Non-Durables | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 7 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | Consumer Non-Durables |
Beijing Tong Ren Tang Ming Qi Group LLC | |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Health Services |
Washington Health System Foundation | Miscellaneous |
- Bolsa de valores
- Insiders
- Wendy Cameron
- Experiencia